Concepedia

Non-hematologic Toxicity Grading

Non-Hematologic Toxicity Grading is a systematic assessment framework used in clinical and pharmacological research to evaluate and classify adverse effects of medical interventions that affect organ systems other than the hematopoietic system, distinguishing it from hematologic toxicity grading by focusing exclusively on non-blood-related physiological toxicities.

58

Publications

1.8K

Citations

536

Authors

185

Institutions

Publications per year

2017–2026

5

Parents

Publications

58

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

Giovanni Luca Ceresoli, B. Castagneto, Paolo Andrea Zucali et al. · British Journal of Cancer · 2008 · 118 citations · Full text

, , +17

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number

John Zalcberg, D.J. Kerr, Leonard W. Seymour et al. · European Journal of Cancer · 1998 · 115 citations

, , +15

Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea

So Hyun Bae, Min-Jung Park, Min Mi Lee et al. · Journal of Korean Medical Science · 2014 · 94 citations · Full text

, , +16

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.

Massimo Offidani, Laura Corvatta, Monica Marconi et al. · PubMed · 2006 · 78 citations

, , +17

Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients

Lijing Jiao, Changsheng Dong, Jiaxiang Liu et al. · Scientific Reports · 2017 · 70 citations · Full text

, , +17

1–5 of 58

Authors

536

  1. AS
    Armando Santoro

    Humanitas University, Italy

    2 publications · 146 citations

    2

    h-index

  2. HS
    Haruhiro Saito

    Kanagawa Prefectural Hospital Organization, Japan

    2 publications · 31 citations

    2

    h-index

  3. YO
    Yasuhiro Oki

    The University of Texas MD Anderson Cancer Center, United States

    2 publications · 94 citations

    2

    h-index

  4. FO
    Fumihiro Oshita

    Kanagawa Prefectural Hospital Organization, Japan

    2 publications · 31 citations

    2

    h-index

  5. KY
    Kouzo Yamada

    Kanagawa Prefectural Hospital Organization, Japan

    2 publications · 31 citations

    2

    h-index

1–5 of 536

Institutions

185

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    17 publications

    490 citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    2 h-index

    10 publications

    289 citations

  3. Mayo Clinic in Arizona

    Scottsdale, United States

    2 h-index

    6 publications

    123 citations

  4. Kanagawa Cancer Center

    Yokohama, Japan

    2 h-index

    2 publications

    31 citations

  5. Keio University

    Tokyo, Japan

    2 h-index

    5 publications

    161 citations

  6. Kanagawa Prefectural Hospital Organization

    Yokohama, Japan

    2 h-index

    2 publications

    31 citations

  7. Humanitas University

    Rozzano, Italy

    2 h-index

    14 publications

    482 citations

  8. Mayo Clinic

    Rochester, United States

    2 h-index

    5 publications

    109 citations

1–8 of 185

Venues

  1. Leukemia & lymphoma/Leukemia and lymphoma

    9 publications · 140 citations

    8

    h-index

  2. Journal of Clinical Oncology

    6 publications · 108 citations

    6

    h-index

  3. PubMed

    Repository · 4 publications · 124 citations

    4

    h-index

  4. Anti-Cancer Drugs

    4 publications · 103 citations

    4

    h-index

  5. BMC Cancer

    3 publications · 58 citations

    3

    h-index

1–5